Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

autologous TAAs-loaded autologous dendritic cells AV-GBM-1

A preparation of autologous dendritic cells (DCs) loaded with immunogenic tumor-associated antigens (TAAs) derived from cultured autologous glioblastoma multiforme (GBM) tumor cells, with potential immunostimulatory and antineoplastic activities. Upon administration, the autologous TAA-loaded DCs AV-GBM-1 expose the immune system to the GBM neoantigens, which results in a cytotoxic T-lymphocyte (CTL)-mediated immune response against the autologous GBM cells leading to GBM cell lysis.
Synonym:autologous dendritic cells loaded with autologous tumor associated antigens
autologous TAAs-loaded autologous DCs AV-GBM-1
neoantigen-loaded autologous dendritic cells AV-GBM-1
Code name:AV GBM 1
AV-GBM-1
Search NCI's Drug Dictionary